263 related articles for article (PubMed ID: 30572460)
1. Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
Wen J; Ma X; Zhang L; Lu X; Yang Y; Wang J; Zhao Y
Medicine (Baltimore); 2018 Dec; 97(51):e13580. PubMed ID: 30572460
[TBL] [Abstract][Full Text] [Related]
2. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis.
Chen L; Wang R; Liu H; Wei S; Jing M; Wang M; Zhao Y
Evid Based Complement Alternat Med; 2021; 2021():6612653. PubMed ID: 33603818
[TBL] [Abstract][Full Text] [Related]
4. [Network Meta-analysis of 11 Chinese patent medicines in treatment of dilated cardiomyopathy].
Wang ZX; Wang H; Ban JF; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6778-6797. PubMed ID: 38212037
[TBL] [Abstract][Full Text] [Related]
5. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of five Chinese medicine injections for treating dilated cardiomyopathy with heart failure: A Bayesian network meta-analysis.
Cao X; Liu H; Zhou M; Chen X; Long D
J Ethnopharmacol; 2022 Jan; 282():114604. PubMed ID: 34499964
[TBL] [Abstract][Full Text] [Related]
8. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.
Zhou Z; Shen W; Yu L; Xu C; Wu Q
J Ethnopharmacol; 2016 Dec; 194():1130-1139. PubMed ID: 27847338
[TBL] [Abstract][Full Text] [Related]
9. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
[TBL] [Abstract][Full Text] [Related]
10. Comparative Efficacy of Different Drugs for the Treatment of Dilated Cardiomyopathy: A Systematic Review and Network Meta-analysis.
Tong X; Shen L; Zhou X; Wang Y; Chang S; Lu S
Drugs R D; 2023 Sep; 23(3):197-210. PubMed ID: 37556093
[TBL] [Abstract][Full Text] [Related]
11. [Network Meta-analysis of six Chinese patent medicines for replenishing Qi and activating blood in treatment of chronic heart failure].
Park YS; Wang W; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4221-4237. PubMed ID: 36046913
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety evaluation of Shenmai injections for dilated cardiomyopathy: A systematic review and meta-analysis of randomised controlled trials.
Wang Y; Liu Q; Kong Y; Zhong G; Wang D
Phytomedicine; 2023 Feb; 110():154630. PubMed ID: 36608499
[TBL] [Abstract][Full Text] [Related]
13. Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis.
Nassiri S; Van de Bovenkamp AA; Remmelzwaal S; Sorea O; de Man F; Handoko ML
Open Heart; 2024 May; 11(1):. PubMed ID: 38719498
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
[TBL] [Abstract][Full Text] [Related]
15. Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
Shi L; Huang L; Yin E; Deng J; Du X
PLoS One; 2023; 18(12):e0295344. PubMed ID: 38048301
[TBL] [Abstract][Full Text] [Related]
16. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
17. Niuhuang Jiangya Preparation (a traditional Chinese patent medicine) for essential hypertension: A systematic review.
Wang H; Liu C; Zhai J; Shang H
Complement Ther Med; 2017 Apr; 31():90-99. PubMed ID: 28434477
[TBL] [Abstract][Full Text] [Related]
18. Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis.
Wang M; Shan Y; Sun W; Han J; Tong H; Fan M; Chen J; Yu P; Shen L; Chen X
Front Pharmacol; 2021; 12():751050. PubMed ID: 34795585
[No Abstract] [Full Text] [Related]
19. Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Zhang X; Ma S; Fu B
Medicine (Baltimore); 2021 Apr; 100(15):e25491. PubMed ID: 33847660
[TBL] [Abstract][Full Text] [Related]
20. Wenxin Keli for Ventricular premature complexes with Heart failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Li M; Qiu R; Tian G; Zhang X; Li C; Chen S; Zhang Q; Shang H
Complement Ther Med; 2017 Aug; 33():85-93. PubMed ID: 28735831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
